Cronos Group

Cronos Group Debt/EBITDA

The Total Debt to EBITDA Ratio of Cronos Group (CRON.TO) as of Oct 27, 2026 is -0.10. In the previous year, Total Debt to EBITDA Ratio was -0.03 — a change of 246.09% (lower).

Debt/EBITDA

-0.10

YoY

246.09%

Last updated:

Total Debt to EBITDA Ratio of Cronos Group is 2025 -0.10 . Total Debt to EBITDA Ratio of Cronos Group was 2024 -0.03 . It decreases by 246.09% lower compared to the previous year.

The Cronos Group Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2018
-1.02 USD
Jan 1, 2019
-0.05 USD
Jan 1, 2020
-0.05 USD
Jan 1, 2021
-0.03 USD
Jan 1, 2022
-0.04 USD
Jan 1, 2023
-0.03 USD
Jan 1, 2024
-0.03 USD
Jan 1, 2025
-0.10 USD
The Cronos Group Debt/EBITDA history
YEARDebt/EBITDAYoY
-0.10+246.09%
-0.03-13.57%
-0.03-11.85%
-0.04+5.83%
-0.03-24.36%
-0.05-6.11%
-0.05-95.24%
-1.02-39.67%
-1.69-7.57%
-1.82-178.27%
2.33-6,509.60%
-0.04—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cronos Group Stock analysis

What does Cronos Group do? Cronos Group Inc is a Canadian company specializing in the production and distribution of medical and recreational cannabis. It was founded in 2013 and is headquartered in Toronto, Canada. Cronos Group Inc is one of the leading cannabis producers in Canada and has also made a name for itself in the international market. History Cronos Group Inc started as a medical cannabis startup focused on the cultivation and production of high-quality cannabis products for the medical market. In 2016, the company was listed on the Toronto Stock Exchange and raised 40 million Canadian dollars through a capital increase. In 2018, it received a $1.8 billion investment from Altria Group Inc, one of the world's largest tobacco companies. This investment helped Cronos grow and establish itself in the global cannabis market. Business model Cronos Group Inc has a diversified business model focusing on the production, processing, and marketing of cannabis products. The company specializes in the cultivation and production of high-quality cannabis products suitable for both the medical and recreational markets. Cronos Group Inc also produces cannabis oils, vaporizer pens, and other smoke-free products. The various subsidiaries Cronos Group Inc consists of several subsidiary companies focusing on different aspects of the cannabis industry. Some of the key subsidiaries of Cronos Group Inc are: 1. Peace Naturals - This company specializes in the cultivation of medical cannabis and also produces cannabis oils and vaporizable products. 2. Original BC - Original BC is a leading provider of recreational cannabis, offering a wide range of cannabis products. 3. Sublime Culture - Sublime Culture specializes in the production of cannabis extracts and the development of novel cannabis products like THC-infused gummy bears. Products Cronos Group Inc offers a wide range of cannabis products suitable for both the medical and recreational markets. Some of the key products of Cronos Group Inc include: 1. Cannabis oils - The company produces a wide range of cannabis oils suitable for medical and recreational use. 2. Vaporizer pens - Cronos Group Inc also produces vaporizable products for smoke-free consumption of cannabis products. 3. Edibles - The company also offers a range of novel cannabis products like THC-infused gummy bears, contributing to the growth of the market. Conclusion Cronos Group Inc is one of the leading cannabis companies worldwide specializing in the production and distribution of medical and recreational cannabis. The company has made a name for itself with its wide range of cannabis products and has grown and established itself in the international market through the investment from Altria Group Inc. Cronos Group Inc has implemented a diversified business model, offering medical cannabis, recreational cannabis, and novel cannabis products to grow in the increasing demand and provide its customers with a wide range of offerings. Cronos Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cronos Group stock

Total Debt to EBITDA Ratio of Cronos Group is -0.10 in 2025.

Total Debt to EBITDA Ratio of Cronos Group changed from -0.03 to -0.10, representing a 246.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Cronos Group since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Cronos Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Cronos Group

All Key Metrics — Cronos Group